Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C E Pippenger

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
JAMA|March 3, 1975
Letter: Acute carbamazepine encephalopathyM Salcman, C E Pippenger
Pediatric Clinics of North America|February 1, 1987
The pediatric acute care laboratoryF Van Lente, C E Pippenger
Therapeutic Drug Monitoring|December 1, 1996
Relationships between carbamazepine-diol, carbamazepine-epoxide, and carbamazepine total and free steady-state concentrations in epileptic patients: the influence of age, sex, and comedicationD A Svinarov, C E Pippenger
The Journal of Pediatrics|June 1, 1976
Pharmacologic observations on the neonatal withdrawal syndromeT S Rosen, C E Pippenger
Clinics in Perinatology|March 1, 1975
Phenobarbital plasma levels in neonatesC E Pippenger, T S Rosen
Addictive Diseases|January 1, 1975
Disposition of methadone and its relationship to severity of withdrawal in the newbornT S Rosen, C E Pippenger
Cleveland Clinic Quarterly|January 1, 1984
An overview of therapeutic drug monitoring principlesC E Pippenger, R P Lesser
Cleveland Clinic Quarterly|January 1, 1985
Theophylline and its interactionsP H Slugg, C E Pippenger
Postgraduate Medicine|March 1, 1985
Choosing an antiepileptic drug. The case for individualized treatmentR P Lesser, C E Pippenger
Journal of Clinical Pharmacology|January 1, 1976
The relation of anticonvulsant drug levels to complete seizure controlR G Feldman, C E Pippenger
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
JAMA|March 3, 1975
Letter: Acute carbamazepine encephalopathyM Salcman, C E Pippenger
Pediatric Clinics of North America|February 1, 1987
The pediatric acute care laboratoryF Van Lente, C E Pippenger
Therapeutic Drug Monitoring|December 1, 1996
Relationships between carbamazepine-diol, carbamazepine-epoxide, and carbamazepine total and free steady-state concentrations in epileptic patients: the influence of age, sex, and comedicationD A Svinarov, C E Pippenger
The Journal of Pediatrics|June 1, 1976
Pharmacologic observations on the neonatal withdrawal syndromeT S Rosen, C E Pippenger
Clinics in Perinatology|March 1, 1975
Phenobarbital plasma levels in neonatesC E Pippenger, T S Rosen
Addictive Diseases|January 1, 1975
Disposition of methadone and its relationship to severity of withdrawal in the newbornT S Rosen, C E Pippenger
Cleveland Clinic Quarterly|January 1, 1984
An overview of therapeutic drug monitoring principlesC E Pippenger, R P Lesser
Cleveland Clinic Quarterly|January 1, 1985
Theophylline and its interactionsP H Slugg, C E Pippenger
Postgraduate Medicine|March 1, 1985
Choosing an antiepileptic drug. The case for individualized treatmentR P Lesser, C E Pippenger
Journal of Clinical Pharmacology|January 1, 1976
The relation of anticonvulsant drug levels to complete seizure controlR G Feldman, C E Pippenger
Pageof 6